Europe

18 Feb 2020

UK Supreme Court case could have big impact on biotech IP strategies

A much-watched dispute over Regeneron transgenic mice patents will affect when and how life sciences innovators seek protection for their increasingly complex inventions

18 Feb 2020

Chinese chipmakers clash over fingerprint recognition tech

A dispute over biometrics continues to ensnare two companies backed by China’s big government chip fund

Latest

View all
17 Feb 2020

Irish NPE doubles down on US litigation campaign and continues to add patents

Recent transfer of more than 50 assets from Microchip Technology suggests there might be more litigation on the way from Neodrón   Read more

15 Feb 2020

The impact of Covid-19 will be felt across the global IP market

The race to patent a treatment for coronavirus in China is heating up, but its spread could be the story that affects every other story in tech this year Read more

14 Feb 2020

Five keys to successful technology licensing with the not-for-profit community

Huge amounts of innovation in the university and wider research worlds remain untapped but there are some clear tips to follow as companies search for new sources of value Read more

14 Feb 2020

Help to choose the IP Hall of Fame inductees for 2020

Nominate someone who deserves recognition for their outstanding, long-term contribution to the IP world Read more

Refine content by:

Designs

View all
18 Dec 2019

US lawmakers sound alarm on China’s WIPO ambitions

China has nominated agency insider Wang Binying for the director general post, but the US is said to favour Singapore's candidate Read more

5 Dec 2019

The search for the world's leading IP strategists is on

IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value Read more

24 Oct 2019

Latest statistics show foreign firms win in high numbers at Beijing IP Court

Numbers also show that damages are rising. But litigation statistics only tell part of the story on plaintiff success. Read more

30 Sep 2019

Europe and Latin America moving to marriage, but IP could be grounds for divorce

The recent trade accord agreed in principle between the EU and Mercosur promises to deliver significant benefits, but political controversies around issues such as data protection and SPCs mean that the deal is not yet sealed Read more

Finance

View all
5 Dec 2019

The search for the world's leading IP strategists is on

IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value Read more

29 Nov 2019

IP market news highlights

IAM’s biggest autumn reads Read more

12 Jun 2019

IAM and sister publication GDR launch major data event

The Data Business Congress will take place in San Jose, CA, next February with the focus on the capture, protection, management, exploitation and monetisation of one of the pivotal assets of the 21st century Read more

3 Jun 2019

Deloitte makes major IP play with acquisition of top advisory

Big Four firm closes deal to acquire UK-based ClearView in a further sign that IP value creation is moving to the centre of the corporate agenda  Read more

FRAND/SEPS

View all
12 Feb 2020

US play for Nokia or Ericsson no long-term 5G solution, says Qualcomm engineering chief

Speaking at an event in Washington DC, Susie Armstrong claims that if policymakers want to help they should support a strong IP system and clarify rules on American participation in standards setting Read more

8 Feb 2020

The inconvenient truth is that the West gifted China its 5G leadership

A lack of foresight and a complete absence of joined up thinking in both the US and Europe have handed Huawei and others huge advantages in a technology space that is set to change the world Read more

7 Feb 2020

Qualcomm and Nokia report licensing numbers in a week to remember for 5G

Chip giant continues to see big uplift after Apple settlement, while Finnish company’s royalty income suggest it is still waiting for significant monetary boost from latest technology Read more

5 Feb 2020

How policy and case law are transforming the ITC as a venue for FRAND disputes

Standards essential patent owners now have a clearer and potentially more favourable option for asserting their rights in the US Read more

Law & Policy

View all
12 Feb 2020

US play for Nokia or Ericsson no long-term 5G solution, says Qualcomm engineering chief

Speaking at an event in Washington DC, Susie Armstrong claims that if policymakers want to help they should support a strong IP system and clarify rules on American participation in standards setting Read more

12 Feb 2020

Cause for concern in German patent reform proposals

Changes to the injunctive relief regime suggested by the Ministry of Justice in a recent discussion paper could significantly weaken IP owners’ rights Read more

10 Feb 2020

The six big ways the US and Europe differ on software patents

With approaches to computer-implemented inventions varying on either side of the Atlantic, there are a series of key distinctions that applicants should be aware of Read more

8 Feb 2020

The inconvenient truth is that the West gifted China its 5G leadership

A lack of foresight and a complete absence of joined up thinking in both the US and Europe have handed Huawei and others huge advantages in a technology space that is set to change the world Read more

Litigation

View all
12 Feb 2020

US play for Nokia or Ericsson no long-term 5G solution, says Qualcomm engineering chief

Speaking at an event in Washington DC, Susie Armstrong claims that if policymakers want to help they should support a strong IP system and clarify rules on American participation in standards setting Read more

12 Feb 2020

Cause for concern in German patent reform proposals

Changes to the injunctive relief regime suggested by the Ministry of Justice in a recent discussion paper could significantly weaken IP owners’ rights Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

5 Feb 2020

How policy and case law are transforming the ITC as a venue for FRAND disputes

Standards essential patent owners now have a clearer and potentially more favourable option for asserting their rights in the US Read more

Market Developments

View all
6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

4 Feb 2020

Pharma companies need data strategies more than ever following recent CJEU decisions

Judgments from Europe’s top court rejecting a presumption of confidentiality for clinical study reports submitted for marketing authorisation have significant implications Read more

1 Feb 2020

We need better thinking on US pharma patent reforms

As the presidential race heats up - and with even self-styled Democrat centrist Michael Bloomberg now promising radical regime change - life sciences IP professionals must interject some sanity into the debate Read more

21 Jan 2020

Four trends that will shape life sciences IP deal-making in 2020

After a record-breaking 2019, here are the key value-creation issues to look out for in the new decade Read more

Non practising entities

View all
12 Feb 2020

Cause for concern in German patent reform proposals

Changes to the injunctive relief regime suggested by the Ministry of Justice in a recent discussion paper could significantly weaken IP owners’ rights Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

28 Jan 2020

Shanghai research group to license SEPs through Sisvel

Langbo Communications Technology CEO Yang Lin tells IAM he’s hoping to build “China’s InterDigital” Read more

22 Jan 2020

Advocacy fight in Europe points to new battleground over patent litigation

Big Tech letter to EU commissioner highlighting danger of "trolls", and the response to it, demonstrate ongoing friction between SEP owners and implementers Read more

Patent pools

View all
29 Jan 2020

Very quietly, Sisvel and Samsung agree another patent pool deal

Luxembourg-based firm secures the South Korean giant as both licensee and licensor in its DVB-T2 programme Read more

28 Jan 2020

Shanghai research group to license SEPs through Sisvel

Langbo Communications Technology CEO Yang Lin tells IAM he’s hoping to build “China’s InterDigital” Read more

21 Jan 2020

Four trends that will shape life sciences IP deal-making in 2020

After a record-breaking 2019, here are the key value-creation issues to look out for in the new decade Read more

16 Dec 2019

Xiaomi seeks Sisvel FRAND rate in Beijing

Chinese smartphone maker follows an increasingly popular playbook, setting up another contest for jurisdiction between European and Chinese courts Read more

Strategy

View all
14 Feb 2020

It’s a tight race for autonomous driving patent leadership

New analysis gives unparalleled insight into the key players in self-drive technologies and shows Waymo, Toyota, GM and Ford vying for top spot Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

4 Feb 2020

Pharma companies need data strategies more than ever following recent CJEU decisions

Judgments from Europe’s top court rejecting a presumption of confidentiality for clinical study reports submitted for marketing authorisation have significant implications Read more

3 Feb 2020

How India’s top research labs instill a culture of patenting

IP leaders from Samsung, Daimler, Tivo and others explain how they get the most out of their local R&D functions Read more

Technology licensing

View all
8 Feb 2020

The inconvenient truth is that the West gifted China its 5G leadership

A lack of foresight and a complete absence of joined up thinking in both the US and Europe have handed Huawei and others huge advantages in a technology space that is set to change the world Read more

7 Feb 2020

Qualcomm and Nokia report licensing numbers in a week to remember for 5G

Chip giant continues to see big uplift after Apple settlement, while Finnish company’s royalty income suggest it is still waiting for significant monetary boost from latest technology Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

5 Feb 2020

How policy and case law are transforming the ITC as a venue for FRAND disputes

Standards essential patent owners now have a clearer and potentially more favourable option for asserting their rights in the US Read more

Trademarks

View all
18 May 2018

Suing a Chinese entity in the United States? Expect a two year wait to serve process

There are a host of challenges when it comes to trying to assert US patents against a Chinese legal entity. A recent court filing by Dutch telecom KPN, which is suing Oppo, Vivo and OnePlus in the District of Delaware, underlines what looks to be a… Read more

8 Apr 2018

Barcelona court reveals 40% rise in fast track protocol activity during this year's Mobile World Congress

If you were to name Europe’s patent litigation hotspots, places like Dusseldorf, Munich, Mannheim, London and The Hague would spring quickly to mind; perhaps followed by the likes of Paris and Milan. One thing is for sure, though: no Spanish city… Read more

5 Apr 2018

For the first time this century Philips does not have a chief IP officer

Very quietly, something of a revolution has taken place at Philips. For the first time this century, the company’s IP function – Philips IP & Standards - is headed up by someone who has no long-term IP background and who is not labelled its chief IP… Read more

30 Mar 2018

Expect patent-heavy pharma acquisitions following Novartis’ $13 billion consumer healthcare divestment

This week saw the headline-grabbing multi-billion dollar sell-off by Novartis of its consumer healthcare business. Reflecting the Swiss entity’s desire to focus resources on strengthening its position in higher-priority therapeutic spaces, the deal… Read more

Trade secrets

View all
12 Feb 2020

Cause for concern in German patent reform proposals

Changes to the injunctive relief regime suggested by the Ministry of Justice in a recent discussion paper could significantly weaken IP owners’ rights Read more

6 Feb 2020

Iancu makes US concerns about possible Chinese WIPO leadership clear 

USPTO head tells Washington DC event that the next head of the organisation must come from a country that “respects intellectual property rights” Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

4 Feb 2020

Pharma companies need data strategies more than ever following recent CJEU decisions

Judgments from Europe’s top court rejecting a presumption of confidentiality for clinical study reports submitted for marketing authorisation have significant implications Read more

Valuation

View all
14 Feb 2020

It’s a tight race for autonomous driving patent leadership

New analysis gives unparalleled insight into the key players in self-drive technologies and shows Waymo, Toyota, GM and Ford vying for top spot Read more

7 Feb 2020

Johnson & Johnson takes the patent lead in medtech innovation

The company has surpassed other healthcare powerhouses and kept Apple and Alphabet at bay, but a robust portfolio does not guarantee smooth sailing Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

4 Feb 2020

Pharma companies need data strategies more than ever following recent CJEU decisions

Judgments from Europe’s top court rejecting a presumption of confidentiality for clinical study reports submitted for marketing authorisation have significant implications Read more